Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arcus Biosciences (RCUS) Amortizatization of Intangibles (2017 - 2025)

Historic Amortizatization of Intangibles for Arcus Biosciences (RCUS) over the last 9 years, with Q3 2025 value amounting to $3.0 million.

  • Arcus Biosciences' Amortizatization of Intangibles fell 5000.0% to $3.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $16.0 million, marking a year-over-year decrease of 3600.0%. This contributed to the annual value of $25.0 million for FY2024, which is 3157.89% up from last year.
  • Per Arcus Biosciences' latest filing, its Amortizatization of Intangibles stood at $3.0 million for Q3 2025, which was down 5000.0% from $3.0 million recorded in Q2 2025.
  • Arcus Biosciences' 5-year Amortizatization of Intangibles high stood at $7.0 million for Q2 2024, and its period low was -$2.2 million during Q4 2021.
  • Moreover, its 5-year median value for Amortizatization of Intangibles was $4.0 million (2023), whereas its average is $3.0 million.
  • As far as peak fluctuations go, Arcus Biosciences' Amortizatization of Intangibles plummeted by 270000.0% in 2021, and later skyrocketed by 40769.23% in 2022.
  • Over the past 5 years, Arcus Biosciences' Amortizatization of Intangibles (Quarter) stood at -$2.2 million in 2021, then soared by 191.07% to $2.0 million in 2022, then surged by 200.0% to $6.0 million in 2023, then changed by 0.0% to $6.0 million in 2024, then tumbled by 50.0% to $3.0 million in 2025.
  • Its Amortizatization of Intangibles was $3.0 million in Q3 2025, compared to $3.0 million in Q2 2025 and $4.0 million in Q1 2025.